Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Charles Sanders Elected to Board of BioCryst Pharmaceuticals

A past NYAS Chairman and retired Glaxo CEO, Sanders will help lead the Birmingham, AL, drug company.

Published January 15, 2010

Charles A. Sanders, a past chairman of the New York Academy of Sciences, has been elected to the board of directors at BioCryst Pharmaceuticals, Inc., in Birmingham, AL. Sanders is retired from Glaxo, Inc., where he served as CEO from 1989-1994 and Chairman of the Board from 1992-1995. Before joining Glaxo, Inc., Sanders spent eight years with Squibb Corp., where he held a number of posts, including the position of vice chairman. He also served as CEO of the Science and Technology Group and chairman of the Science and Technology Committee of the Board. Previously he was general director of Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. A native of Dallas, he is a graduate of Southwestern Medical College of the University of Texas.